- August 6, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Cinqair
Synonyms :
reslizumab
Class :
Drugs for asthma and COPD & Anti-Asthmatic (monoclonal antibody)
Brand Name :
Cinqair
Synonyms :
reslizumab
Class :
Drugs for asthma and COPD & Anti-Asthmatic (monoclonal antibody)
Dosage Forms & Strengths
Solution, Intravenous:
100 mg/10ml
severe asthma:
3
mg/kg
over 20 to 50 minutes
4
weeks
No safe and efficacious dosing indicated
Refer to adult dosing
may reduce the therapeutic effect of vaccines
poliovirus vaccine, live, trivalent
may reduce the therapeutic effect of vaccines
poliovirus vaccine inactivated
may reduce the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may reduce the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
may reduce the therapeutic effect of vaccines
may reduce the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
may reduce the therapeutic effect of vaccines
may reduce the therapeutic effect of vaccines
may decrease the therapeutic effect of COVID-19 vaccine
may increase the immunosuppressive effect of tacrolimus
may decrease the therapeutic effect when combined with influenza virus vaccines
may decrease the therapeutic effect when combined with rabies vaccine
may decrease the therapeutic effect when combined with sipuleucel-t
may decrease the therapeutic effect when combined with vaccines
may have an increased immunosuppressive effect when combined with immunosuppressants
may have an increased immunosuppressive effect when combined with leflunomide
may decrease the diagnostic effect when combined with coccidioides immitis test
may decrease the therapeutic effect when combined with COVID-19 vaccine
may increase the immunosuppressive effect of immunosuppressive agents
may have an increased immunosuppressive effect when combined with immunosuppressants
may have an increased immunosuppressive effect when combined with baricitinib
may have an increased adverse effect when combined with dengue tetravalent vaccine
may have an increased immunosuppressive effect when combined with immunosuppressants
may increase the immunosuppressive effect of tacrolimus
may have an increased adverse effect when combined with nadofaragene firadenovec
may have an increased immunosuppressive effect when combined with natalizumab
may have an increased immunosuppressive effect when combined with immunosuppressants
may have an increased immunosuppressive effect when combined with ruxolitinib
may have an increasingly adverse effect when combined with talimogene laherparepvec
may have an increased immunosuppressive effect when combined with tofacitinib
may have an increased immunosuppressive effect when combined with upadacitinib
poliovirus vaccine, live, trivalent
may enhance the adverse/toxic effect
poliovirus vaccine inactivated
may enhance the adverse/toxic effect
measles, mumps, rubella, and varicella vaccine, live (Rx)
may enhance the adverse/toxic effect
measles mumps and rubella vaccine, live
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
smallpox (vaccinia) vaccine, live
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may have an increasingly adverse effect when combined with immunosuppressants
methotrexate can also enhance the immunosuppressive effect of tacrolimus (Topical)
respiratory syncytial virus vaccine, adjuvanted
may reduce the therapeutic effect of vaccines
respiratory syncytial virus (RSV) vaccine
may reduce the therapeutic effect of vaccines
may have an increased adverse effect when combined with BCG products
may have an increased immunosuppressive effect when combined with cladribine
may increase the therapeutic effect of immunosuppressants
may decrease the therapeutic effect when combined with brincidofovir
may have an increased immunosuppressive effect when combined with inebilizumab
may have an increased immunosuppressive effect when combined with ocrelizumab
may have an increased immunosuppressive effect when combined with ofatumumab
may decrease the therapeutic effect when combined with pidotimod
may have an increased immunosuppressive effect when combined with immunosuppressants
may have an increased immunosuppressive effect when combined with immunosuppressants
may have an increased immunosuppressive effect when combined with immunosuppressants
may have an increased immunosuppressive effect when combined with ublituximab
may have an increased immunosuppressive effect when combined with tacrolimus
Frequency defined:
>10%
Antibody development
Myalgia
Increased creatinine phosphokinase
<1%
Anaphylaxis
Pregnancy consideration: only preferred if conventional therapies do not work to treat asthma in pregnancy.
Lactation: Reslizumab excretion in breast milk is not known.
Pregnancy category:
Patient information leaflet
Generic Name: Reslizumab
Pronounced: res-li-zu-mab
Why do we use reslizumab?
Reslizumab is used to treat asthma. For asthma attack use a rescue inhaler and talk with your doctor.